RADIOIODINE TREATMENT OF GRAVES’ DISEASE – DOSE/RESPONSE ANALYSIS

The clinical outcome of 153 Graves’ disease patients treated with a wide dose range of radioactive iodine-131 (RAI) was analyzed retrospectively. Six to nine months after the first dose of RAI 60 patients (39%) were hypothyroid (or rather thyroxine-substituted) and 26 (17%) were euthyroid, while 67...

Full description

Bibliographic Details
Main Authors: Jitka Čepková, Jiří Horáček, Jaroslav Vižďa, Jiří Doležal
Format: Article
Language:English
Published: Karolinum Press 2014-01-01
Series:Acta Medica
Subjects:
Online Access:https://actamedica.lfhk.cuni.cz/57/2/0049/